Veradigm | MDRX - Pendapatan Penjualan





Penjualan Perubahan Tanggal
Alcidion AUD 25.47M 2.32M 2025-12
Ambu A/S DKK 1.57B 10M 2026-03
Amplifon EUR 579.9M 72.1M 2026-03
Cardinal Health USD 60.9B 4.73B 2026-03
Centene USD 49.94B 210M 2026-03
Charles River Laboratories USD 995.8M 1.6M 2026-03
Cigna USD 68.52B 3.95B 2026-03
Coloplast 7.04B 83M 2025-12
Computer Programs Systems USD 87.79M 3.96M 2025-12
Convatec Group USD 1.26B 80M 2025-12
CVS Health USD 100.4B 5.3B 2026-03
Diasorin EUR 292.51M 2.49M 2026-03
Elevance Health USD 49.5B 200M 2026-03
General Electric Aerospace USD 11.6B 270M 2026-03
Gulf Medical Proj AED 213.77M 25.43M 2025-12
Humana USD 39.65B 7.13B 2026-03
IQVIA Holdings USD 4.15B 210M 2026-03
Laboratory Of America USD 3.54B 20M 2026-03
Maximus USD 1.31B 40M 2026-03
McKesson USD 92.3B 13.86B 2026-03
Med Life RON 787.96M 8.36M 2025-09
Molina Healthcare USD 10.8B 580M 2026-03
Omnicell USD 309.88M 4.12M 2026-03
Oriola-kd EUR 502M 38.7M 2025-12
Owens Minor USD 708.97M 11.71M 2025-12
Quest Diagnostics USD 2.9B 90M 2026-03
Rede D'or Sao Luiz BRL 14.56B 180M 2026-03
Siemens Healthineers EUR 5.68B 280M 2026-03
Sonova Holding CHF 1.82B 216.8M 2025-12
Supermax Corporation Bhd MYR 126.8M 60.64M 2026-03
UnitedHealth USD 111.7B 1.5B 2026-03
Veeva Systems USD 835.95M 24.72M 2025-12
Veradigm USD 142.52M 9.38M 2022-12
Xerox USD 2.03B 70M 2025-12